Protein corona-mediated targeting of nanocarriers to B cells allows redirection of allergic immune responses.
Shen L, Tenzer S, Storck W, Hobernik D, Raker VK, Fischer K, Decker S, Dzionek A, Krauthäuser S, Diken M, Nikolaev A, Maxeiner J, Schuster P, Kappel C, Verschoor A, Schild H, Grabbe S, Bros M.
Shen L, et al. Among authors: bros m.
J Allergy Clin Immunol. 2018 Nov;142(5):1558-1570. doi: 10.1016/j.jaci.2017.08.049. Epub 2018 Jan 31.
J Allergy Clin Immunol. 2018.
PMID: 29382591
Free article.